Serotonin and dopamine are neurotransmitters, chemical messengers that help nerve cells communicate. Both are essential for mental health, but they affect the brain in different ways.
- Serotonin helps regulate mood, sleep, appetite, and digestion. It’s closely tied to feelings of well-being and emotional stability.
- Dopamine is central to motivation, reward, and movement. It drives the “wanting” that pushes you to pursue goals, which differs from the pleasure of getting them.
While they’re often linked to happiness, their roles in the brain are far more nuanced.
Serotonin Vs. Dopamine
Below are some of the main differences between serotonin and dopamine:
| Feature | Serotonin | Dopamine |
|---|---|---|
| Chemical family | Indoleamine (built on an indole ring) | Catecholamine (built on a catechol ring) |
| Made from | Tryptophan, an essential amino acid | Tyrosine, an amino acid |
| Main cell bodies | Raphe nuclei, a midline cluster in the brain stem | The midbrain (VTA and substantia nigra) |
| Wiring | Diffuse, reaching almost the whole nervous system | Focused pathways for reward, cognition, and movement |
| Main job | Mood, sleep, appetite, digestion, and restraint | Wanting, motivation, reward learning, and movement |
| Firing style | Slow and steady (tonic), shifting with behavioural state | Brief bursts (phasic) tied to specific events |
| Receptors | About 14 subtypes (5-HT1 to 5-HT7) | Five subtypes (D1 to D5) |
| Effect on target cells | Excitatory or inhibitory, depending on the receptor | Excitatory or inhibitory, depending on the receptor |
| Signature drugs | Antidepressant SSRIs, migraine triptans, psychedelics | Antipsychotics, L-DOPA (for Parkinson’s disease), stimulants |
| Linked conditions (associations, not proven causes) | Depression, anxiety, OCD, impulsive aggression | Parkinson’s disease, schizophrenia, addiction, ADHD |
| Popular label | “Happiness chemical,” yet also tied to restraint and aversion | “Pleasure chemical,” yet it drives wanting more than liking |
Table: Serotonin vs. dopamine
How Serotonin and Dopamine Are Made
Both are monoamines: small signalling molecules built from a single amino acid. They belong to different chemical families and come from different dietary building blocks.
- Dopamine: a catecholamine made from the amino acid tyrosine. The enzyme tyrosine hydroxylase controls the first, rate-limiting step.
- Serotonin: an indoleamine made from tryptophan, an essential amino acid the body cannot make. Tryptophan hydroxylase controls its rate-limiting step.
Because tryptophan must compete with other amino acids to enter the brain, serotonin production is unusually sensitive to diet. An acute tryptophan-depletion drink, which lowers the supply of serotonin’s precursor, can measurably lower brain serotonin within hours (Delgado et al., 1990). Dopamine has no equally clean lever.
The two systems converge when they switch off. A dedicated transporter recovers each chemical from the synapse, the gap between neurons: the dopamine transporter (DAT) and the serotonin transporter (SERT). The enzyme monoamine oxidase then breaks both down, which is why older MAOI antidepressants raise dopamine, serotonin, and noradrenaline together.
What does serotonin do?
Serotonin plays a crucial role in regulating mood, and it also influences sleep, appetite, memory, attention, and reward processing.
It is not a simple “happiness chemical,” though. A major umbrella review found no consistent evidence that low serotonin causes depression (Moncrieff et al., 2022).
Serotonin is made mainly by neurons in the raphe nuclei, a strip of cell clusters along the midline of the brain stem. Their axons fan out to almost the entire central nervous system, including the cortex, nucleus accumbens, cerebellum, and hippocampus.
That wide reach makes serotonin a tone-setting system. Its firing is slow, steady, and state-dependent: fastest during active waking and near-silent in REM (dreaming) sleep.
Its effects are not purely inhibitory. Serotonin acts through many receptor types, some inhibitory and some excitatory, depending on which brain cells it reaches.
Interestingly, most serotonin is found outside the brain, in the gastrointestinal tract, where it promotes healthy digestion.
What does dopamine do?
Dopamine plays a key role in the brain’s reward system and motivation. It is not simply a “pleasure chemical.”
Research shows dopamine drives “wanting”: the pull toward a reward and its cues. This differs from “liking”, the actual pleasure of receiving it (Berridge & Robinson, 1998).
The distinction matters. Dopamine neurons are concentrated in the midbrain, especially the ventral tegmental area (VTA) and substantia nigra. From there, their axons follow a few focused pathways. Three matter most.
The mesolimbic pathway runs from the VTA to the nucleus accumbens. It is the classic reward-and-motivation circuit. It also reaches the amygdala and hippocampus, supporting reward, emotion, and memory.
The mesocortical pathway differs: it projects to the frontal lobes, supporting higher cognitive function, attention, and motivated decision-making.
The nigrostriatal pathway runs from the substantia nigra to the dorsal striatum and is essential for starting voluntary movement. Its loss causes the motor symptoms of Parkinson’s disease.
How Do They Affect Mental Health?
Changes in either neurotransmitter are linked to various mental health challenges, though not as simple single causes:
- Serotonin is implicated in depression, anxiety, OCD, social anxiety, irritability, and sleep problems. Low serotonin has not been shown to cause depression (Moncrieff et al., 2022).
- Low dopamine is tied to fatigue, lack of motivation, difficulty focusing, and a reduced sense of pleasure. It plays a role in conditions like ADHD, Parkinson’s disease, and the low-drive side of depression (Dunlop & Nemeroff, 2007).
- Excess dopamine has been linked to psychosis and the positive symptoms of schizophrenia, such as hallucinations.
How Drugs Act on Each System
The two systems respond to different drugs, which is one of the clearest signs that they are separate.
- SSRIs: selective serotonin reuptake inhibitors block the serotonin transporter, raising serotonin in the synapse.
- Other serotonin drugs: triptans abort migraine through 5-HT1B/1D receptors, and psychedelics such as LSD and psilocybin act at 5-HT2A (Carhart-Harris & Nutt, 2017).
- Antipsychotics: relieve psychosis mainly by blocking D2 receptors, one of five dopamine receptor subtypes (D1 to D5).
- L-DOPA: replenishes dopamine synthesis in Parkinson’s disease and substantially reduced rigidity, tremor, and slowness in an early controlled trial (Cotzias et al., 1969).
- Stimulants: cocaine and amphetamine flood the reward pathway by blocking or reversing the dopamine transporter. Prescribed stimulants act on the same pathway in ADHD (Volkow et al., 2009).
A network meta-analysis of 21 antidepressants found every one more effective than placebo for acute major depression. The drugs still differed in efficacy and tolerability (Cipriani et al., 2018).
Yet an SSRI helps because it reliably raises synaptic serotonin, not because low serotonin has been shown to cause depression. Mechanism and theory come apart. A prescriber can apply the first while staying agnostic about the second.
Do Serotonin and Dopamine Work Together?
Yes. While they often operate in separate pathways, serotonin and dopamine systems do interact.
- Serotonin can influence dopamine activity. Some serotonin receptors (such as 5-HT2C) act as a brake on dopamine neurons, while others (such as 5-HT2A) can boost them.
- In impulsive aggression, low serotonin function in the prefrontal cortex and high dopamine function add together (Seo et al., 2008).
Because the two systems modulate each other, the balance between them matters more than the level of either alone.
Researchers call this opponency. Dopamine energises approach toward reward, while serotonin restrains action, especially when punishment looms. The two act like an accelerator and a brake (Boureau & Dayan, 2011; Cools et al., 2011).
The fit is imperfect. Serotonin’s role is broader and less well defined than dopamine’s. Some theorists see both as parts of one learning system rather than true opposites (Cools et al., 2011).
Several conditions involve both transmitters, so a single-chemical explanation is incomplete:
- Depression: low drive and slowed movement map onto blunted dopamine-driven reward pursuit, alongside serotonin’s mood role (Dunlop & Nemeroff, 2007).
- Addiction: dopamine’s reward pathway fuels drug wanting, while serotonin shapes the impulse control that decides whether wanting becomes action.
- Schizophrenia: the disorder is anchored in dopamine, yet drugs that also block serotonin 5-HT2A receptors work with fewer movement side effects.
- Parkinson’s disease: mainly dopamine loss, but serotonin neurons also degenerate, depression is common, and serotonin neurons help convert L-DOPA to dopamine.
How to Naturally Boost Serotonin and Dopamine
Supporting these neurotransmitters through lifestyle habits can help improve your mood, energy, and overall well-being.
- Move Your Body: aerobic exercise, like running, dancing, or brisk walking, boosts both serotonin and dopamine release.
- Get Some Sunlight: daily sunlight helps regulate serotonin and your circadian rhythm. Aim for 15 minutes outdoors.
- Prioritize Restful Sleep: a consistent bedtime and sleep-friendly environment support healthy serotonin and dopamine regulation.
- Practice Mindfulness: meditation and deep breathing lower stress and boost serotonin release, and may support dopamine-linked attention.
- Build Social Bonds: laughing with friends, physical affection, and feeling understood can raise both serotonin and dopamine naturally.
Treat “boosting” as shorthand, not a mechanism. Claims about a “dopamine hit” or a “serotonin boost for happiness” describe a process the evidence does not support (see Critical Evaluation below).
Critical Evaluation
Serotonin and dopamine are often marketed as simple “happy chemicals.” The research does not support that framing. Three criticisms matter most.
- The “Happy Chemical” Myth: neither transmitter is really about pleasure; dopamine drives wanting, serotonin governs restraint, and neither maps onto simple happiness.
- The Chemical-Imbalance Oversimplification: the claim that low serotonin causes depression has not survived a major evidence review.
- Treating Them as Separate Systems: serotonin and dopamine constantly influence each other, so studying either alone misses how they work together.
These criticisms target the slogans, not the science. The chemical and anatomical contrast is secure: different precursors, enzymes, brain regions, and receptor families. The functional contrast is well supported too, but it is a weighted contrast rather than a clean split.
The “Happy Chemical” Myth
Animal studies expose the flaw directly. When researchers destroy most of an animal’s dopamine neurons, it still shows normal “liking” reactions to a sweet taste.
Yet it loses almost all motivation to go and get that same reward. This shows dopamine drives “wanting.” That is the pull toward a reward and its cues. It matters far less for “liking”, the pleasure of consuming it (Berridge & Robinson, 1998).
Even the reward signal itself is not enjoyment.
It is a reward-prediction error: a signal reporting how much better or worse an outcome was than expected (Schultz, 1998).
Serotonin fails the same test from the other side. Lowering brain serotonin does not simply make people unhappy.
It selectively disrupts punishment-induced behavioural inhibition, the ability to slow down when an action risks punishment. General motor control stays intact (Crockett et al., 2009).
Serotonin depletion also blunts how strongly people represent reward value, cutting against the idea of serotonin as a purely “calm” chemical (Seymour et al., 2012).
A “dopamine hit” or a “serotonin boost for happiness” describes a mechanism the evidence does not support.
The Chemical-Imbalance Oversimplification
A systematic umbrella review pooled decades of evidence on serotonin and depression. It found no consistent evidence that depression is caused by lowered serotonin activity or concentration (Moncrieff et al., 2022). The simple “low serotonin causes depression” story does not hold.
Brain-imaging studies sometimes find the opposite of what the theory predicts. One study found an over-active, not under-active, serotonin system in people with social anxiety disorder (Frick et al., 2015). That is a striking reversal.
The picture is genuinely mixed.
None of this makes SSRIs or dopaminergic drugs useless. Their efficacy never depended on the imbalance theory being true. A treatment can help without the disorder being a simple deficiency of that drug’s target.
The same caution applies to claims about a simple “low dopamine” cause for low mood.
The response to the failed imbalance theory has not been to swap one monoamine for another. The most influential alternative is the glutamate hypothesis.
It locates the core problem in impaired synaptic plasticity, the ability of connections between neurons to change and rewire. The key players are the excitatory transmitter glutamate and its inhibitory partner GABA (Sanacora et al., 2012).
Ketamine blocks one type of glutamate receptor, the NMDA receptor. It produces antidepressant effects within hours, far faster than any SSRI. A plasticity account explains that speed more easily than a monoamine account (Duman & Aghajanian, 2012).
This does not make serotonin and dopamine irrelevant. SSRIs and dopaminergic drugs still work, and both systems are regulated by glutamate and GABA neurons.
What changes is the level of explanation. Serotonin and dopamine become two of several modulators of the brain’s excitation-inhibition balance, not the whole story.
Treating Them as Separate Systems
Serotonin and dopamine are not independent. Serotonin neurons project onto dopamine cell groups in the midbrain, and some serotonin receptors brake dopamine activity while others facilitate it.
Atypical antipsychotics exploit exactly this coupling. They combine weaker dopamine-receptor blockade with serotonin-receptor antagonism, treating psychosis with fewer movement side effects than older drugs that block dopamine alone. That is direct clinical evidence the two systems can regulate each other.
Impulsive aggression makes the same point.
It is best predicted by the combination of low serotonin function and high dopamine function together, not by either alone (Seo et al., 2008).
Much of the human evidence linking either transmitter to a single disorder is correlational brain-imaging data (Frick et al., 2015; Lin et al., 2014). It cannot show that a difference causes a condition rather than resulting from it.
Correlation is not causation.
The strongest causal evidence instead comes from animal studies and human depletion experiments. That is why the balance between the two systems, not the level of either alone, is usually the variable that matters clinically.
Serotonin and Punishment
Two dissociation studies pin down what serotonin actually does, separate from dopamine.
The first tackles punishment.
- Aim: Crockett et al. (2009) tested whether serotonin governs how we process unpleasant events or the separate ability to hold back action under threat of punishment.
- Method: In a double-blind, placebo-controlled study, healthy volunteers had brain serotonin lowered by acute tryptophan depletion, a dietary drink that lowers serotonin’s precursor. A task then measured motor restraint, punishment-linked slowing, and punishment sensitivity separately.
- Results: After placebo, volunteers slowed down under threat of punishment. Depleting serotonin abolished this punishment-linked slowing, while general motor restraint and punishment sensitivity stayed intact.
- Conclusion: Serotonin is critical for punishment-induced behavioural inhibition specifically, not for restraint or aversion in general. This is the mechanism behind the “serotonin as brake” idea.
The effect was selective: only punishment-linked slowing disappeared.
Serotonin and Reward Value
- Aim: Seymour et al. (2012) tested whether serotonin’s role is limited to punishment or also shapes how reward itself is valued.
- Method: In a double-blind, placebo-controlled design, researchers lowered brain serotonin by tryptophan depletion. During fMRI, participants did a task where actions led independently to money and mild pain, and modelling separated the two effects.
- Results: Serotonin depletion selectively impaired both the behavioural and neural representation of reward value. This was distinct from a separate rise in repeating previous choices regardless of outcome.
- Conclusion: Serotonin does not confine itself to punishment: it plays a specific role in representing reward value. That complicates any simple “dopamine equals reward” story.
This challenges any strict reward/punishment divide.
Contemporary Research
A 2015 study resolved much of this uncertainty by recording serotonin and dopamine neurons directly, in the same animals, during the same task.
The design was elegant.
- Aim: Cohen et al. (2015) tested what identified serotonin neurons signal during reward and punishment, comparing them directly with dopamine neurons in the same task.
- Method: Researchers recorded dorsal raphe neurons in mice as rewards and punishments varied across blocks of trials. Optogenetic tagging, which uses light to confirm a neuron’s identity, showed which were truly serotonergic.
- Results: Many serotonin neurons shifted their firing rate slowly, over minutes, across blocks; most were excited by punishments, and some by reward-predicting cues. Dopamine neurons showed no slow, block-wide changes.
- Conclusion: Serotonin neurons carry information about both reward and punishment on multiple timescales, including a slow, state-setting code that dopamine neurons lack.
The finding challenges any neat “dopamine equals reward, serotonin equals punishment” split.
Dopamine carries a fast, event-linked signal. Serotonin adds a slow, background one, and the two are best read as continuously calibrating each other rather than working in isolation.
Summary
Serotonin and dopamine each influence your mental health, but in different ways. Serotonin sets a steady background tone of mood, sleep, and restraint. Dopamine drives the wanting behind motivation and reward.
Both are vital to well-being, and both can be supported through healthy habits. Understanding these differences empowers you to take small, meaningful steps toward better mood, focus, and resilience.
Key Takeaways
- Different Jobs: Dopamine drives wanting, motivation, and movement. Serotonin sets a background tone of mood, sleep, appetite, and restraint.
- Happiness Myth: Neither is a pleasure chemical. Dopamine drives wanting more than liking, and serotonin is tied to restraint as much as good mood.
- Opponency: Dopamine energises approach while serotonin restrains it, but serotonin also shapes reward value, so the contrast is not clean.
- Interaction: The two systems modulate each other, so the balance between them often matters more than either level alone.
- Depression Evidence: An umbrella review found no consistent evidence that low serotonin causes depression, though SSRIs can still help (Moncrieff et al., 2022).
- Different Drugs: SSRIs target serotonin, while antipsychotics, L-DOPA, and stimulants act on dopamine.
References
Berridge, K. C., & Robinson, T. E. (1998). What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Research Reviews, 28 (3), 309-369. https://doi.org/10.1016/S0165-0173(98)00019-8
Boureau, Y.-L., & Dayan, P. (2011). Opponency revisited: Competition and cooperation between dopamine and serotonin. Neuropsychopharmacology, 36 (1), 74-97. https://doi.org/10.1038/npp.2010.151
Carhart-Harris, R. L., & Nutt, D. J. (2017). Serotonin and brain function: A tale of two receptors. Journal of Psychopharmacology, 31 (9), 1091-1120. https://doi.org/10.1177/0269881117725915
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J. P. A., & Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet, 391 (10128), 1357-1366. https://doi.org/10.1016/S0140-6736(17)32802-7
Cohen, J. Y., Amoroso, M. W., & Uchida, N. (2015). Serotonergic neurons signal reward and punishment on multiple timescales. eLife, 4, e06346. https://doi.org/10.7554/eLife.06346
Cools, R., Nakamura, K., & Daw, N. D. (2011). Serotonin and dopamine: Unifying affective, activational, and decision functions. Neuropsychopharmacology, 36 (1), 98-113. https://doi.org/10.1038/npp.2010.121
Cotzias, G. C., Papavasiliou, P. S., & Gellene, R. (1969). Modification of Parkinsonism: Chronic treatment with L-dopa. New England Journal of Medicine, 280 (7), 337-345. https://doi.org/10.1056/NEJM196902132800701
Crockett, M. J., Clark, L., & Robbins, T. W. (2009). Reconciling the role of serotonin in behavioral inhibition and aversion: Acute tryptophan depletion abolishes punishment-induced inhibition in humans. Journal of Neuroscience, 29 (38), 11993-11999. https://doi.org/10.1523/JNEUROSCI.2513-09.2009
Delgado, P. L., Charney, D. S., Price, L. H., Aghajanian, G. K., Landis, H., & Heninger, G. R. (1990). Serotonin function and the mechanism of antidepressant action: Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Archives of General Psychiatry, 47 (5), 411-418. https://doi.org/10.1001/archpsyc.1990.01810170011002
Duman, R. S., & Aghajanian, G. K. (2012). Synaptic dysfunction in depression: Potential therapeutic targets. Science, 338 (6103), 68-72. https://doi.org/10.1126/science.1222939
Dunlop, B. W., & Nemeroff, C. B. (2007). The role of dopamine in the pathophysiology of depression. Archives of General Psychiatry, 64 (3), 327-337. https://doi.org/10.1001/archpsyc.64.3.327
Eske, J. (2019, August 19). Dopamine and serotonin: Brain chemicals explained. Medical News Today. https://www.medicalnewstoday.com/articles/326090
Frick, A., Åhs, F., Engman, J., Jonasson, M., Alaie, I., Björkstrand, J., Frans, Ö., Faria, V., Linnman, C., Appel, L., Wahlstedt, K., Lubberink, M., Fredrikson, M., & Furmark, T. (2015). Serotonin synthesis and reuptake in social anxiety disorder: A positron emission tomography study. JAMA Psychiatry, 72 (8), 794-802. https://doi.org/10.1001/jamapsychiatry.2015.0125
Juarez Olguin, H., Calderon Guzman, D., Hernandez Garcia, E., & Barragan Mejia, G. (2016). The role of dopamine and its dysfunction as a consequence of oxidative stress. Oxidative medicine and cellular longevity, 2016.
Lin, S. H., Lee, L. T., & Yang, Y. K. (2014). Serotonin and mental disorders: a concise review on molecular neuroimaging evidence. Clinical Psychopharmacology and Neuroscience, 12 (3), 196.
Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2022). The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular Psychiatry, 28, 3243-3256. https://doi.org/10.1038/s41380-022-01661-0
Sanacora, G., Treccani, G., & Popoli, M. (2012). Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology, 62 (1), 63-77. https://doi.org/10.1016/j.neuropharm.2011.07.036
Schultz, W. (1998). Predictive reward signal of dopamine neurons. Journal of Neurophysiology, 80 (1), 1-27. https://doi.org/10.1152/jn.1998.80.1.1
Seo, D., Patrick, C. J., & Kennealy, P. J. (2008). Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggression and Violent Behavior, 13 (5), 383-395. https://doi.org/10.1016/j.avb.2008.06.003
Seymour, B., Daw, N. D., Roiser, J. P., Dayan, P., & Dolan, R. (2012). Serotonin selectively modulates reward value in human decision-making. Journal of Neuroscience, 32 (17), 5833-5842. https://doi.org/10.1523/JNEUROSCI.0053-12.2012
Vandergriendt, C. (2020, July 16). What the Difference Between Dopamine and Serotonin? Healthline. https://www.healthline.com/health/dopamine-vs-serotonin
Volkow, N. D., Wang, G.-J., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F., Fowler, J. S., Zhu, W., Logan, J., Ma, Y., Pradhan, K., Wong, C., & Swanson, J. M. (2009). Evaluating dopamine reward pathway in ADHD: Clinical implications. JAMA, 302 (10), 1084-1091. https://doi.org/10.1001/jama.2009.1308
Further Reading
- Carhart-Harris, R. L., & Nutt, D. J. (2017). Serotonin and brain function: a tale of two receptors. Journal of Psychopharmacology, 31(9), 1091-1120.
- Harmer, C. J., Duman, R. S., & Cowen, P. J. (2017). How do antidepressants work? New perspectives for refining future treatment approaches. The Lancet Psychiatry, 4(5), 409-418.
- Olivier B. Serotonin: A never-ending story. European Journal of Pharmacology. 2015;753:2-18.
- Cowen, P. J., & Browning, M. (2015). What has serotonin to do with depression?. World Psychiatry, 14(2), 158.
